Clinical Utility in Maximizing CD34 + Cell Count in Stem Cell Grafts
- 1 November 1999
- journal article
- review article
- Published by Oxford University Press (OUP) in The International Journal of Cell Cloning
- Vol. 17 (6) , 373-376
- https://doi.org/10.1002/stem.170373
Abstract
Many different stem cell subsets have been identified. Some of these subsets are multipotent, able to develop into any one of several cell types, while other stem cell subsets are committed to differentiated myeloid, lymphoid, erythroid, or megakaryocytic lineages.Keywords
This publication has 10 references indexed in Scilit:
- Stem cell component therapy: supplementation of unmanipulated marrow with CD34 enriched peripheral blood stem cellsBone Marrow Transplantation, 1999
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1998
- T cell-depleted granulocyte colony-stimulating factor (G-CSF) modified allogeneic bone marrow transplantation for hematological malignancy improves graft CD34+ cell content but is associated with delayed pancytopeniaBone Marrow Transplantation, 1998
- Allogeneic Peripheral Blood Stem Cell Transplantation May Be Associated With a High Risk of Chronic Graft-Versus-Host DiseaseBlood, 1997
- Granulocyte Colony-Stimulating Factor Reduces the Capacity of Blood Mononuclear Cells to Induce Graft-Versus-Host Disease: Impact on Blood Progenitor Cell TransplantationBlood, 1997
- Potential role of CD34 stem cells in tolerance inductionTransplantation Proceedings, 1997
- Relationship of CD34+ cell dose to early and late hematopoiesis following autologous peripheral blood stem cell transplantationBone Marrow Transplantation, 1997
- Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated miceNature Medicine, 1995
- Subsets of CD34+ cells and rapid hematopoietic recovery after peripheral-blood stem-cell transplantation.Journal of Clinical Oncology, 1995